TY  - ADVS
AU  - Luzzatto,Lucio
TI  - Complement in PNH and other hemolytic anaemias: part 3 of 3 
T2  - The complement system,
PY  - 2017///
CY  - London
PB  - Henry Stewart Talks
KW  - Complement (Immunology)
KW  - Hemolytic anemia
KW  - Immunologic diseases
KW  - Paroxysmal hemoglobinuria
KW  - Anemia, Hemolytic
KW  - Antibodies, Monoclonal, Humanized
KW  - Bone Marrow
KW  - Complement Activation
KW  - drug effects
KW  - Complement System Proteins
KW  - eculizumab
KW  - Erythrocytes
KW  - Hemoglobinuria, Paroxysmal
KW  - drug therapy
KW  - pathology
KW  - Hemolysis
KW  - Iatrogenic Disease
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Complement-targeted therapy for PNH -- Mechanism of (iatrogenic) hemolysis in PNH -- Pathogenesis of PNH -- Anaemias due to intravascular hemolysis -- Bone marrow failure and PNH -- Somatic mutations in PNH -- Clinical burden of PNH -- PNH: issues in management -- Eculizumab (anti-C5 Ab): targeted therapy for PNH; Access restricted to subscribers
UR  - https://hstalks.com/bs/3542/
UR  - https://hstalks.com/bs/p/1036/
ER  -